Details for New Drug Application (NDA): 019368
✉ Email this page to a colleague
The generic ingredient in MOCTANIN is monoctanoin. Additional details are available on the monoctanoin profile page.
Summary for 019368
Tradename: | MOCTANIN |
Applicant: | Ethitek |
Ingredient: | monoctanoin |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | LIQUID;PERFUSION, BILIARY | Strength | 100% | ||||
Approval Date: | Oct 29, 1985 | TE: | RLD: | No |
Expired US Patents for NDA 019368
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Ethitek | MOCTANIN | monoctanoin | LIQUID;PERFUSION, BILIARY | 019368-001 | Oct 29, 1985 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription